iBio
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	6/30/2022	6/30/2023	6/30/2024	6/30/2026	6/30/2027	6/30/2028
Revenue % change YoY	$2.38M N/A	$0 -100%	$225K 0%	Avg: $2M Low: $2M High: $2M avg. 788.88%	Avg: $8M Low: $8M High: $8M avg. 300%	Avg: $24M Low: $24M High: $24M avg. 200%
Net Income % change YoY	$-51.00M N/A	$-29.31M 42.53%	$-24.90M 15.02%	Avg: $-936.74K Low: $-936.74K High: $-936.74K avg. 96.23%	Avg: $-440.82K Low: $-440.82K High: $-440.82K avg. 52.94%	Avg: $-30.61K Low: $-30.61K High: $-30.61K avg. 93.05%
EBITDA % change YoY	$-45.70M N/A	$-28.12M 38.47%	$-14.02M 50.14%	Avg: $-1.2M Low: $-1.2M High: $-1.2M avg. 91.44%	Avg: $-4.8M Low: $-4.8M High: $-4.8M avg. -300%	Avg: $-14.4M Low: $-14.4M High: $-14.4M avg. -200%
EPS % change YoY	-$2,924.26 N/A	-$47.87 98.36%	-$6.5 86.42%	Avg: -$1.53 Low: -$1.53 High: -$1.53 avg. 76.46%	Avg: -$0.72 Low: -$0.72 High: -$0.72 avg. 52.94%	Avg: -$0.05 Low: -$0.05 High: -$0.05 avg. 93.05%
Operating Expenses % change YoY	$51.85M N/A	$29.34M -43.41%	$16.85M -42.54%	Avg: $15.32M Low: $15.32M High: $15.32M avg. -9.10%	Avg: $61.29M Low: $61.29M High: $61.29M avg. 300.00%	Avg: $183.89M Low: $183.89M High: $183.89M avg. 200.00%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 80.74% in 2026-2028.

We have gathered data from N/A analysts. Their low estimate is -936.74K, average is -936.74K and high is -936.74K.

Wall Street analysts forecast annual average revenue growth of 429.62% in 2026-2028.

We have gathered data from 1 analysts. Their low revenue estimate is $2M, average is $2M and high is $2M.

Wall Street analysts forecast annual average earnings growth of 74.15% in 2026-2028.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.53, average is -$1.53 and high is $-1.53.